Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LSS | P48449 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2352010 | 0.91 | HTR2A (0.52) | HTR2AHRH3SLC6A9KDM4ESMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2351409 | 0.90 | HTR2A (0.51) | HTR2AHRH3SLC6A9KDM4ESMN1; SMN2 | |
| SCHEMBL23074687 | 0.84 | SLC6A9 (0.42) | HTR2ASLC6A9ALDH1A1 | |
| SCHEMBL23074644 | 0.84 | KDM4E (0.51) | HRH3MEN1KMT2ANFE2L2KDM4E | |
| SCHEMBL23074671 | 0.83 | ALDH1A1 (0.53) | LTA4HSMN1; SMN2ALDH1A1 | |
| SCHEMBL23074702 | 0.83 | PARP10 (0.39) | HTR2ASLC6A9LTA4HALDH1A1LSS | |
| SCHEMBL23074657 | 0.82 | SLC6A2 (0.40) | ALDH1A1 | |
| SCHEMBL23074674 | 0.81 | HRH3 (0.47) | HRH3LTA4HMEN1LMNAHTT | |
| SCHEMBL23074701 | 0.81 | ALDH1A1 (0.43) | LTA4HNFE2L2ALDH1A1 | |
| SCHEMBL23074699 | 0.81 | ALDH1A1 (0.43) | LTA4HNFE2L2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | BIO-RAD LABORATORIES, INC. | 2021-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069692-A1 | ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE CHROMATOGRAPHY RESINS | ABCG2, SLC7A1, MSR1 | HTR2A 1461/4885HRH3 10/4885SLC6A9 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.